The number of patients taking immunosuppressive drugs for the management of autoimmune inflammatory conditions is increasing.The general practitioner needs to be active in preventing, monitoring and managing the adverse effects of these drugs even long after the treatment has ceased.monitoring is required because immunosuppressive drugs increase the risks of infection, malignancy, cardiovascular disease and bone marrow suppression.Some drugs have additional risks which require specific monitoring.Vigilance is needed as adverse effects may have atypical clinical presentations.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: